2/2
© Reuters. FILE PHOTO: Test tubes are seen in front of displayed Pfizer and Biontech logos in this illustration taken, May 21, 2021. REUTERS/Dado Ruvic/Illustration
2/2
© Reuters. FILE PHOTO: Test tubes are seen in front of displayed Pfizer and Biontech logos in this illustration taken, May 21, 2021. REUTERS/Dado Ruvic/Illustration2/2
(Reuters) – Pfizer Inc (NYSE:) and its German partner BioNTech SE (NASDAQ:) fired back on Monday at a patent lawsuit filed by Moderna (NASDAQ:) Inc in Boston federal court over their rival COVID-19 vaccines, seeking a dismissal of the lawsuit and a court order that they did not infringe Moderna’s patents.
